Characteristics | Â |
---|---|
Number of patients | 29 |
Age (years), median (IQR) | 39.0 (35.5–44.0) |
Gender, male, n (%) | 26 (89.7) |
BMI (kg/m2), median (IQR) | 20.2 (18.7–23.6) |
Current smoking, n (%) | 12 (41.4) |
Prior AIDS diagnosis, n (%) | 10 (34.5) |
Time since diagnosis HIV (years), median (IQR) | 4 (1–9) |
HIV-RNA < 50 copies/mL, n (%) | 29 (100) |
CD4 cell count (cells/µL), median (IQR) | 438 (301–805) |
Time on antiretroviral therapy (years), median (IQR) | 4 (1–8) |
Backbone drug | |
 TAF/FTC, n (%) | 13 (44.8) |
 TDF/FTC, n (%) | 10 (34.5) |
 ABC/3TC, n (%) | 6 (20.7) |
Key drug class | |
 INSTI, n (%) | 18 (62.1) |
 PI, n (%) | 10 (34.5) |
 NNRTI, n (%) | 1 (3.4) |
 Number of non-HIV medications, median (IQR) | 2 (1–4) |
 Use of ≥ 5 non-HIV medications, n (%) | 1 (3.4) |
 Serum-corrected Ca (mg/dL), median (IQR) | 9.2 (9.0–9.4) |
 BP pre-treatment, n (%) | 6 (20.7) |
 Lumbar spine BMD (g/cm2), median (IQR) | 0.798 (0.753–0.873) |
 Femoral neck BMD (g/cm2), median (IQR) | 0.606 (0.570–0.660) |